SIS International Delivers Faster EMEA Healthcare Insights

Presented by Test GB Basic 3

CHALLENGE

Global pharmaceutical and medical device clients required robust, compliant market research across the EMEA region that could reach healthcare professionals (HCPs) and patients in multiple countries and languages. Clients struggled with recruiting hard-to-reach HCPs, ensuring consistent data quality across markets, managing translations and local moderation, and navigating differing regulatory and privacy requirements. The stakes were high: delays or gaps in insight risked slowing product launches, weakening market positioning, increasing development and go-to-market costs, and potentially jeopardizing regulatory or payer submissions.

SOLUTION

SIS International delivered an end-to-end EMEA healthcare research solution tailored to these needs. Leveraging a deep, region-wide recruitment network of HCPs and patients, multilingual moderators, and turnkey project management, SIS handled recruitment, scheduling, translation/local moderation, compliance (including local privacy requirements), and centralized reporting. The service combined qualitative and quantitative methodologies as required by the client, ensuring consistent study protocols and high-quality fieldwork across multiple markets.

RESULT

Clients received timely, high-quality, and compliant insights from across the EMEA region. SIS met recruitment targets for diverse HCP and patient samples, reduced fielding timelines through coordinated multilingual logistics, and delivered harmonized reporting that enabled cross-market comparisons. The research informed product positioning, clinical messaging, and launch planning, helping clients move forward with greater confidence and fewer delays in their EMEA commercialization activities.

Presented by

Test GB Basic 3

Consulting

Featured Expert

Test GB Basic 3

Consulting

Short Description test

Sign Up for
Updates

Get content that matters, written by top insights industry experts, delivered right to your inbox.

67k+ subscribers